Nandrolone Decanoate EP impurity F

IMPURITIES

Product Details

CAT No.# CS-O-33393
Category Impurities
CAS N
Molecular Weight 442.63
Molecular Formula C28H42O4
Purity: >98
Synonyms: (8R,9S,10R,13S,14S,17S)-13-methyl-3,6-dioxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl decanoate; 3,6-dioxoestr-4-en-17beta-yl decanoate
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. Nandrolone Decanoate EP impurity G
2. Nandrolone Decanoate EP impurity H
3. Nandrolone Decanoate EP impurity K
4. Levosimendan Impurity 2a
5. Nandrolone Decanoate EP impurity I
6. Nandrolone Decanoate EP impurity L
7. (R,E)-2-amino-N'-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-2-oxoacetohydrazonoyl cyanide
8. 2-(2-Methoxyethoxy)ethyl chloride
9. 4-(Acetylamino)phthalic anhydride
10. 7-O-demethyl Prazosin
11. 6-O-demethyl Prazosin
12. N-(4-Aminophenylethyl)-2-phenylacetamide
13. (R)-N-(4-Aminophenethyl)-2-hydroxy-2-phenylethanamide
14. Mirabegron Impurity 30
15. 1-methyl-2-(2,2,2-trifluoroethoxy)benzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridine
16. 2-(((1H-benzo[d]imidazol-2-yl)thio)(1-methyl-2-(2,2,2-trifluoroethoxy)benzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-12-yl)methyl)-3-methylpyridin-4-ol
17. N-(2-benzamidoethyl)-N-(5,8,11,14-tetrabenzoyl-1-oxo-1- phenyl-2,5,8,11,14-pentaazahexadecan-16-yl)benzamide
18. Memantine Hydrochloride (1380502)
19. 12-(((1H-benzo[d]imidazol-2-yl)thio)(3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)-1-methyl-2-(2,2,2-trifluoroethoxy)benzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridine
20. Dosulepin Hydrochoride EP impurity-E


Smileys:
C[C@@]1([C@H]2OC(CCCCCCCCC)=O)[C@](CC2)([H])[C@@](CC3=O)([H])[C@]([C@](CC4)([H])C3=CC4=O)([H])CC1



This page contains information about Nandrolone Decanoate EP impurity F Cas N and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."